These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

424 related items for PubMed ID: 19919943

  • 1. Circulating microparticles remain associated with complement activation despite intensive anti-inflammatory therapy in early rheumatoid arthritis.
    van Eijk IC, Tushuizen ME, Sturk A, Dijkmans BA, Boers M, Voskuyl AE, Diamant M, Wolbink GJ, Nieuwland R, Nurmohamed MT.
    Ann Rheum Dis; 2010 Jul; 69(7):1378-82. PubMed ID: 19919943
    [Abstract] [Full Text] [Related]

  • 2. Increased IgG on cell-derived plasma microparticles in systemic lupus erythematosus is associated with autoantibodies and complement activation.
    Nielsen CT, Østergaard O, Stener L, Iversen LV, Truedsson L, Gullstrand B, Jacobsen S, Heegaard NH.
    Arthritis Rheum; 2012 Apr; 64(4):1227-36. PubMed ID: 22238051
    [Abstract] [Full Text] [Related]

  • 3. C-reactive protein in myocardial infarction binds to circulating microparticles but is not associated with complement activation.
    van der Zee PM, Biró E, Trouw LA, Ko Y, de Winter RJ, Hack CE, Sturk A, Nieuwland R.
    Clin Immunol; 2010 Jun; 135(3):490-5. PubMed ID: 20138585
    [Abstract] [Full Text] [Related]

  • 4. Time-course of health status in patients with rheumatoid arthritis during the first year of treatment with infliximab.
    Ban A, Inaba M, Furumitsu Y, Okamoto K, Yukioka K, Goto H, Nishizawa Y.
    Biomed Pharmacother; 2010 Feb; 64(2):107-12. PubMed ID: 19944558
    [Abstract] [Full Text] [Related]

  • 5. High anti-collagen type-II antibody levels and induction of proinflammatory cytokines by anti-collagen antibody-containing immune complexes in vitro characterise a distinct rheumatoid arthritis phenotype associated with acute inflammation at the time of disease onset.
    Mullazehi M, Mathsson L, Lampa J, Rönnelid J.
    Ann Rheum Dis; 2007 Apr; 66(4):537-41. PubMed ID: 17040962
    [Abstract] [Full Text] [Related]

  • 6. Complement activation in patients with rheumatoid arthritis mediated in part by C-reactive protein.
    Molenaar ET, Voskuyl AE, Familian A, van Mierlo GJ, Dijkmans BA, Hack CE.
    Arthritis Rheum; 2001 May; 44(5):997-1002. PubMed ID: 11352263
    [Abstract] [Full Text] [Related]

  • 7. The effect of antirheumatic drugs on circulating immune complexes in rheumatoid arthritis.
    Forster PJ, McConkey B.
    Q J Med; 1986 Jan; 58(225):29-42. PubMed ID: 2871585
    [Abstract] [Full Text] [Related]

  • 8. Effect of spironolactone on endothelial dysfunction in rheumatoid arthritis.
    Syngle A, Vohra K, Kaur L, Sharma S.
    Scand J Rheumatol; 2009 Jan; 38(1):15-22. PubMed ID: 18766955
    [Abstract] [Full Text] [Related]

  • 9. Association of baseline levels of urinary glucosyl-galactosyl-pyridinoline and type II collagen C-telopeptide with progression of joint destruction in patients with early rheumatoid arthritis.
    Garnero P, Gineyts E, Christgau S, Finck B, Delmas PD.
    Arthritis Rheum; 2002 Jan; 46(1):21-30. PubMed ID: 11817593
    [Abstract] [Full Text] [Related]

  • 10. Infliximab treatment reduces complement activation in patients with rheumatoid arthritis.
    Familian A, Voskuyl AE, van Mierlo GJ, Heijst HA, Twisk JW, Dijkmans BA, Hack CE.
    Ann Rheum Dis; 2005 Jul; 64(7):1003-8. PubMed ID: 15958758
    [Abstract] [Full Text] [Related]

  • 11. Potential novel biomarkers of disease activity in rheumatoid arthritis patients: CXCL13, CCL23, transforming growth factor alpha, tumor necrosis factor receptor superfamily member 9, and macrophage colony-stimulating factor.
    Rioja I, Hughes FJ, Sharp CH, Warnock LC, Montgomery DS, Akil M, Wilson AG, Binks MH, Dickson MC.
    Arthritis Rheum; 2008 Aug; 58(8):2257-67. PubMed ID: 18668547
    [Abstract] [Full Text] [Related]

  • 12. Advanced glycation end-products inhibition improves endothelial dysfunction in rheumatoid arthritis.
    Syngle A, Vohra K, Garg N, Kaur L, Chand P.
    Int J Rheum Dis; 2012 Feb; 15(1):45-55. PubMed ID: 22324946
    [Abstract] [Full Text] [Related]

  • 13. Circulating leptin and adiponectin concentrations during tumor necrosis factor blockade in patients with active rheumatoid arthritis.
    Popa C, Netea MG, de Graaf J, van den Hoogen FH, Radstake TR, Toenhake-Dijkstra H, van Riel PL, van der Meer JW, Stalenhoef AF, Barrera P.
    J Rheumatol; 2009 Apr; 36(4):724-30. PubMed ID: 19273452
    [Abstract] [Full Text] [Related]

  • 14. Elevated levels of platelet microparticles are associated with disease activity in rheumatoid arthritis.
    Knijff-Dutmer EA, Koerts J, Nieuwland R, Kalsbeek-Batenburg EM, van de Laar MA.
    Arthritis Rheum; 2002 Jun; 46(6):1498-503. PubMed ID: 12115179
    [Abstract] [Full Text] [Related]

  • 15. Circulating TNFRI and TNFRII levels correlated with the disease activity score (DAS28) in rheumatoid arthritis.
    Valle Y, Ledezma-Lozano IY, Torres-Carrillo N, Padilla-Gutiérrez JR, Navarro-Hernández RE, Vázquez-Del Mercado M, Palafox-Sánchez CA, Armendáriz-Borunda J, Muñoz-Valle JF.
    Scand J Rheumatol; 2009 Jun; 38(5):332-5. PubMed ID: 19579138
    [Abstract] [Full Text] [Related]

  • 16. Circulating levels of matrix metalloproteinases MMP-3 and MMP-1, tissue inhibitor of metalloproteinases 1 (TIMP-1), and MMP-1/TIMP-1 complex in rheumatic disease. Correlation with clinical activity of rheumatoid arthritis versus other surrogate markers.
    Keyszer G, Lambiri I, Nagel R, Keysser C, Keysser M, Gromnica-Ihle E, Franz J, Burmester GR, Jung K.
    J Rheumatol; 1999 Feb; 26(2):251-8. PubMed ID: 9972954
    [Abstract] [Full Text] [Related]

  • 17. Serum matrix metalloproteinase 3 levels during treatment with sulfasalazine or combination of methotrexate and sulfasalazine in patients with early rheumatoid arthritis.
    Posthumus MD, Limburg PC, Westra J, van Leeuwen MA, van Rijswijk MH.
    J Rheumatol; 2002 May; 29(5):883-9. PubMed ID: 12022344
    [Abstract] [Full Text] [Related]

  • 18. Inflammation and microvascular and macrovascular endothelial dysfunction in rheumatoid arthritis: effect of treatment.
    Foster W, Carruthers D, Lip GY, Blann AD.
    J Rheumatol; 2010 Apr; 37(4):711-6. PubMed ID: 20156948
    [Abstract] [Full Text] [Related]

  • 19. Serum amyloid A in the assessment of early inflammatory arthritis.
    Cunnane G, Grehan S, Geoghegan S, McCormack C, Shields D, Whitehead AS, Bresnihan B, Fitzgerald O.
    J Rheumatol; 2000 Jan; 27(1):58-63. PubMed ID: 10648018
    [Abstract] [Full Text] [Related]

  • 20. P-selectin as a circulating molecular marker in rheumatoid arthritis with thrombocytosis.
    Ertenli I, Kiraz S, Arici M, Haznedaroglu IC, Calgüneri M, Celik I, Kirazli S.
    J Rheumatol; 1998 Jun; 25(6):1054-8. PubMed ID: 9632062
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.